✦ LIBER ✦

Maternal psychiatric disorders in pediatric inflammatory bowel disease and cystic fibrosis

✍ Scribed by Patrick M. Burke; Samuel Kocoshis; Deborah Neigut; Jennifer Sauer; R. Chandra; D. Orenstein

Publisher: Springer US
Year: 1994
Tongue: English
Weight: 572 KB
Volume: 25
Category: Article
ISSN: 0009-398X
DOI: 10.1007/bf02251099

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thromboembolism in pediatric inflammator

Thromboembolism in pediatric inflammatory bowel disease: Systematic review

✍ Marzia Lazzerini; Matteo Bramuzzo; Massimo Maschio; Stefano Martelossi; Alessand 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB 👁 1 views

Background: Several studies suggest an increased risk of venous and arterial thromboembolism (TE) in adults with inflammatory bowel disease (IBD) compared to the general population. We performed a systematic review of studies on incidence and characteristic of TE in children with IBD. Methods: We s

Nutritional concerns in pediatric inflam

Nutritional concerns in pediatric inflammatory bowel disease patients

✍ Michael D. Kappelman; Athos Bousvaros 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

## Abstract In approximately one‐fourth of patients with Crohn's disease (CD) and ulcerative colitis (UC), disease onset occurs during childhood and adolescence. In addition to gastrointestinal and extraintestinal symptoms of inflammatory bowel disease (IBD), children with these conditions often ex

Bone mineral metabolism in pediatric inf

Bone mineral metabolism in pediatric inflammatory bowel disease

✍ Dr. Robert M. Issenman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 766 KB

The development of reliable techniques to measure bone densitometry and evolving effective drug treatment have kindled great interest in the diagnosis and treatment of osteoporosis in adults with inflammatory bowel disease. A number of studies have examined the prevalence of abnormal bone mineral me

Cerebral thromboembolic events in pediat

Cerebral thromboembolic events in pediatric patients with inflammatory bowel disease

✍ A.R. Barclay; J.M. Keightley; I. Horrocks; V. Garrick; P. McGrogan; R.K. Russell 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 1 views

## Background: There is a recognized association between pediatric inflammatory bowel disease (ibd) and cerebral thromboembolic events (ctes). historical reporting had described the association as strongest between ulcerative colitis (uc), rather than crohn's disease (cd). we describe the incidence

Mesalamine in pediatric inflammatory bow

Mesalamine in pediatric inflammatory bowel disease: A 10-year experience

✍ Ian D. D'Agata; Tsafrir Vanounou; Dr. Ernest Seidman 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 711 KB

Mesalamine is an enteric-coated 5-aminosalicylic acid formulation effective in the treatment of ulcerative colitis, and in decreasing the relapse rate in Crohn's disease. However, little data are available regarding its use in children and adolescents. To determine the modalities of use, safety, and

Fecal calprotectin is useful in predicti

Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease

✍ Dorota Walkiewicz; Steven L. Werlin; Daryl Fish; Mathew Scanlon; Patrick Hanaway 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Background: Fecal calprotectin (FC) has been proposed as a noninvasive surrogate marker to determine the degree of intestinal inflammation and predicting relapse in patients with inflammatory bowel disease (IBD). The aim was to compare FC levels in IBD and healthy controls, to correlate FC levels wi